Article
ARM-X: an Adaptable Mesenchymal Stromal Cell-based Vaccination Plaftorm Suitable for Solid Tumors
2025-04-23
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> In addition to triggering endosomal escape, the Accum<sup>®</sup> platform was recently reported for its ability to instill antigen cross-presentation properties in mesenchymal stromal cells (MSCs). Despite the promising results obtained with the first-generation vaccine using the A1 Accum<sup>®</sup> derivative (ARM vaccine), large quantities of cancer antigens...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5d418c72-7125-58be-8dde-b5228da1f07d
- DOI
- 10.21203/rs.3.rs-5828115/v1
